Here are the top 5 articles for the month of August.
Transcript:
Hi, I’m Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of August.
Number 5: In a survey, employers indicated that they are taking a more activist role in delivering healthcare to their employees. They also expressed frustration with the pharmaceutical supply chain and said they expect to see a large uptake of virtual healthcare in the coming years.
Number 4: Ohio announced that it will end its contracts with all of its pharmacy benefit managers and start over with transparent ones.
Number 3: CMS announced that it will end the so-called 25% rule for long-term care hospitals and approved add-on payments estimated to cost about 72 million dollars for CAR T-cell therapy.
Number 2: Celyad’s Investigational New Drug application for CYAD-101 received FDA approval, making it the first non—gene-edited allogeneic clinical program for CAR T-cell therapy.
Number 1: During the Office of the National Coordinator for Health IT’s second Interoperability Forum, CMS administrator Seema Verma painted a future where health data follows the patient and can be shared with a doctor at the click of a button.
To read all of these articles and more, visit AJMC.com.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen